Skip to search formSkip to main contentSkip to account menu

VAdriaC Regimen

Known as: VAdriaC, Vincristine-Adriamycin-Cyclophosphamide Regimen 
A regimen consisting of vincristine, doxorubicin and cyclophosphamide, used for the treatment of localized childhood Ewing's sarcoma.
National Institutes of Health

Related topics

Related topics

3 relations
CyclophosphamideDoxorubicinVincristine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Pegfilgrastim in pediatric sarcoma patients undergoing dose-intensive chemotherapy: Phase II study results.
10024 Background: Children with cancer undergoing dose-intensive chemotherapy often require G-CSF support. Patients (pts) < 2 yrs… 
2015
2015
Exenteration and Custom Implant Brachytherapy as a Treatment for Recurrent Primary Extraskeletal Orbital Ewing Sarcoma.
A 6-year-old boy initially presented to an outside hospital with a right orbital mass with biopsy positive for translocation… 
Review
2000
Review
2000
A para-testicular primitive neuroectodermal tumor in an adult: a case report and literature review.
OBJECTIVE The authors describe the salient clinical, radiologic and histopathologic features of an extremely rare para-testicular… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)